Biochemical Properties of Gastrokine-1 Purified from Chicken Gizzard Smooth Muscle by Karim Hnia (127778)

“…We focused on the F-actin interaction with gastrokine-1 and the potential role and function in smooth muscle contractile properties.…”

Data. by Aroon La-up (14095691)

“…The mean U-Cd levels in males (7.18 ± 1.35 μg/g creatinine) were significantly higher (p < 0.001) than in females (3.68 ± 2.13 μg/g creatinine). …”

The data underlying the graphs shown in Figs 1–5. by Fukuaki L. Kinoshita (21533193)

Comparison of <i>Killer-Rescue</i> and split <i>ClvR</i> genetics. by Georg Oberhofer (3401438)

Constructing Asymmetrical Ni-Centered {NiN₂O₄} Octahedra in Layered Metal–Organic Structures for Near-Room-Temperature Single-Phase Magnetoelectricity by Kaihui Mao (9110845)

“…The change in ME polarization with increasing applied magnetic field μ₀<i>H</i> from 0 to 2 T decreases linearly from 0.041 to 0.011 μC/cm² at the strongest ME coupling temperature of 251 K. …”

Constructing Asymmetrical Ni-Centered {NiN₂O₄} Octahedra in Layered Metal–Organic Structures for Near-Room-Temperature Single-Phase Magnetoelectricity by Kaihui Mao (9110845)

“…The change in ME polarization with increasing applied magnetic field μ₀<i>H</i> from 0 to 2 T decreases linearly from 0.041 to 0.011 μC/cm² at the strongest ME coupling temperature of 251 K. …”

Constructing Asymmetrical Ni-Centered {NiN₂O₄} Octahedra in Layered Metal–Organic Structures for Near-Room-Temperature Single-Phase Magnetoelectricity by Kaihui Mao (9110845)

“…The change in ME polarization with increasing applied magnetic field μ₀<i>H</i> from 0 to 2 T decreases linearly from 0.041 to 0.011 μC/cm² at the strongest ME coupling temperature of 251 K. …”

Constructing Asymmetrical Ni-Centered {NiN₂O₄} Octahedra in Layered Metal–Organic Structures for Near-Room-Temperature Single-Phase Magnetoelectricity by Kaihui Mao (9110845)

“…The change in ME polarization with increasing applied magnetic field μ₀<i>H</i> from 0 to 2 T decreases linearly from 0.041 to 0.011 μC/cm² at the strongest ME coupling temperature of 251 K. …”

Presentation1_Increasing maternal age associates with lower placental CPT1B mRNA expression and acylcarnitines, particularly in overweight women.pdf by Hannah E. J. Yong (9738523)

“…We assessed CPT1A, CPT1B, CPT1C and CPT2 mRNA expression by qPCR in 77 placentas and quantified 10 medium and long-chain acylcarnitines by LC-MS/MS in a subset of 50 placentas. …”

Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Data_Sheet_1_Palmitic Acid Reduces the Autophagic Flux and Insulin Sensitivity Through the Activation of the Free Fatty Acid Receptor 1 (FFAR1) in the Hypothalamic Neuronal Cell Li... by María Paz Hernández-Cáceres (6505025)

“…Whether malfunction of autophagy specifically in hypothalamic neurons decreases insulin sensitivity remains unknown. PA does activate the Free Fatty Acid Receptor 1 (FFAR1), also known as G protein-coupled receptor 40 (GPR40); however, whether FFAR1 mediates the effects of PA on hypothalamic autophagy and insulin sensitivity has not been shown. …”

Data_Sheet_1_Palmitic Acid Reduces the Autophagic Flux and Insulin Sensitivity Through the Activation of the Free Fatty Acid Receptor 1 (FFAR1) in the Hypothalamic Neuronal Cell Li... by María Paz Hernández-Cáceres (6505025)

“…Whether malfunction of autophagy specifically in hypothalamic neurons decreases insulin sensitivity remains unknown. PA does activate the Free Fatty Acid Receptor 1 (FFAR1), also known as G protein-coupled receptor 40 (GPR40); however, whether FFAR1 mediates the effects of PA on hypothalamic autophagy and insulin sensitivity has not been shown. …”

Normalized formulas and explanations. by Xianzhuang Shao (22766120)

“…By comparing the Brier scores, it was found that the models with better predictive performance were those using the SPEI-1 and SPEI-12 timescales. We also found that in the near and medium term of the future, with climate change, the forest fire occurrence probability in most forest land of northern China (NWC, NC, and NEC), especially in Northeast China (NEC), shows an increasing trend, but a decreasing trend in most forest land of southern China (SC, SWC, and EC). …”

Supplementary Material for: Influence of Cyclooxygenase-1 Genotype on ex vivo Aspirin Response in Patients at Risk for Stroke by Momary K.M. (4120123)

“…<i>Background:</i> We sought to determine whether cyclooxygenase-1 <i>(PTGS1)</i> genotype is associated with the ability of aspirin to inhibit platelet aggregation in patients at risk for stroke. …”

Data_Sheet_1_Isoprenaline modified the lipidomic profile and reduced β-oxidation in HL-1 cardiomyocytes: In vitro model of takotsubo syndrome.docx by Ivana Fiserova (12228665)

“…The present study demonstrates that acute exposure to ISO decreased ATP production by up to 42.2%, and prolonged exposure to ISO decreased β-oxidation by 86.4%. …”

Table_1_Lipolysis-Stimulated Lipoprotein Receptor Impairs Hepatocellular Carcinoma and Inhibits the Oncogenic Activity of YAP1 via PPPY Motif.docx by Xin Dong (196020)

“…In addition, to evaluate the interaction between LSR and yes-associated protein1 (YAP1), we mutated LSR at PPPY motif, a binding site of YAP1.…”